Tobacco plants having altered amounts of one or more alkaloids in leaf and methods of using such plants

Patent metadata

Field	Value
Publication number	US-10813318-B2
Application number	US-201815914033-A
Country	US
Kind code	B2
Filing date	Mar 7, 2018
Priority date	Dec 6, 2013
Publication date	Oct 27, 2020
Grant date	Oct 27, 2020

Abstract

This disclosure provides a number of sequences involved in the transport of alkaloids from the root to the leaf in tobacco, methods of using such sequences, tobacco plants carrying modifications to such sequences, and tobacco products made from such plants.

First claim

What is claimed is:

1. A Nicotiana tabacum plant having an induced mutation in an endogenous gene, wherein a naturally occurring sequence of said endogenous gene has the sequence shown in SEQ ID NO:15, wherein the mutation results in reduced expression of the endogenous gene relative to a corresponding plant lacking the mutation, wherein leaf from the plant exhibits a reduced amount of at least one alkaloid relative to leaf from a corresponding plant lacking the mutation.

2. The N. tabacum plant of claim 1 , wherein cured leaf from the plant exhibits a reduced amount of at least one tobacco specific nitrosamine (TSNA) relative to cured leaf from a corresponding plant lacking the mutation.

3. Seed produced by the N. tabacum plant of claim 1 , wherein the seed comprises the induced mutation.

4. A method of making a tobacco plant, comprising the steps of:
(a) inducing mutagenesis in Nicotiana tabacum cells to produce mutagenized cells;
(b) obtaining one or more plants from the mutagenized cells;
(c) identifying at least one of the plants that comprises a mutation in an endogenous gene, wherein said endogenous gene has the sequence shown in SEQ ID NO:15, wherein the mutation results in reduced expression of the endogenous gene relative to a corresponding plant lacking the mutation; and
(d) identifying at least one of the plants that comprises leaf that exhibits a reduced amount of at least one alkaloid relative to leaf from a corresponding plant lacking the mutation.

5. The method of claim 4 , further comprising identifying at least one of the plants that comprises leaf that, when cured, exhibits a reduced amount of at least one tobacco-specific nitrosamine (TSNA) relative to cured leaf from a plant lacking the mutation.

6. The method of claim 4 , wherein mutagenesis is induced using a chemical mutagen or ionizing radiation.

7. The method of claim 6 , wherein the chemical mutagen is selected from the group consisting of nitrous acid, sodium azide, acridine orange, ethidium bromide, and ethyl methane sulfonate (EMS).

8. The method of claim 6 , wherein the ionizing radiation is selected from the group consisting of x-rays, gamma rays, fast neutron irradiation, and UV irradiation.

9. The method of claim 4 , wherein mutagenesis is induced using TALEN.

10. The method of claim 4 , wherein mutagenesis is induced using zinc-finger technology.

11. A method for producing a tobacco plant, said method comprising the steps of:
(a) crossing at least one plant of a first tobacco line with at least one plant of a second tobacco line, the plant of the first tobacco line having a mutation in an endogenous gene, wherein a naturally occurring sequence of said endogenous gene has the sequence shown in SEQ ID NO:15, wherein the mutation results in reduced expression of the endogenous gene relative to a corresponding plant lacking the mutation, wherein leaf from the plant of the first tobacco line exhibits a reduced amount of at least one alkaloid relative to leaf from a corresponding plant lacking the mutation;
(b) selecting for progeny tobacco plants that have the mutation and exhibit reduced expression of the endogenous gene relative to a corresponding plant lacking the mutation; and
(c) selecting for progeny tobacco plants that comprise leaf exhibiting a reduced amount of at least one alkaloid relative to leaf from a corresponding plant lacking the mutation.

12. The method of claim 11 , further comprising selecting for progeny tobacco plants that comprise leaf that, when cured, exhibit a reduced amount of at least one tobacco-specific nitrosamine (TSNA) relative to cured leaf from a plant lacking the mutation.

13. A tobacco product comprising cured leaf from a tobacco plant having a mutation in an endogenous gene, wherein said endogenous gene has the sequence shown in SEQ ID NO:15, wherein the mutation results in reduced expression of the endogenous gene relative to a corresponding plant lacking the mutation, wherein the leaf exhibits a reduced amount of at least one alkaloid relative to leaf from a corresponding plant lacking the mutation.

14. The tobacco product of claim 13 , wherein the cured leaf exhibits a reduced amount of at least one tobacco-specific nitrosamine (TSNA) relative to cured leaf from a plant lacking the mutation.

15. A method of producing a tobacco product, the method comprising:
(a) providing cured leaf from a tobacco plant having a mutation in an endogenous gene, wherein said endogenous gene has having the sequence shown in SEQ ID NO:15, wherein the mutation results in reduced expression of the endogenous gene relative to a corresponding plant lacking the mutation, wherein the leaf exhibits a reduced amount of at least one alkaloid relative to leaf from a corresponding plant lacking the mutation; and
(b) manufacturing a tobacco product using the cured leaves.

16. The method of claim 15 , wherein the cured leaf exhibits a reduced amount of at least one tobacco-specific nitrosamine (TSNA) relative to cured leaf from a plant lacking the mutation.

17. The method of claim 15 , wherein the mutation is selected from the group consisting of a point mutation, an insertion, a deletion, and a substitution.

Assignees

• Altria Client Services Llc

Inventors

• Frederick Jesse
• Shen Yanxin
• Xu Dongmei
• Warek Ujwala
• Strickland James Arthur

Classifications

• C07K14/415 Primary

  from plants · CPC title

• A01H6/823 Primary

  Nicotiana, e.g. tobacco · CPC title

• A01H5/12 Primary

  Leaves · CPC title

• C12Q2600/156

  Polymorphic or mutational markers · CPC title

• C12N15/8243

  involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine · CPC title